Pharma article - August 8, 2014
Europe boosts cooperation with international partners on generics
The European Union’s decentralised procedure is being used as a model to accelerate the assessment of applications for generic medicines as part of the International Generic Drug Regulators Pilot. The EU is currently leading an international pilot project through which it will share the assessment reports generated as part of the decentralised procedure in real […]
Clinical Trials - August 7, 2014
Dignitana completes patient recruitment in pivotal trial
The medical cooling devices company announce that it has completed patient recruitment in the multi-center pivotal trial of the patented DigniCap System. Dignitana is conducting a Premarket Approval (PMA), a regulatory process with the aim to obtain product and market approval for the DigniCap System in the United States (U.S.) by the Food and Drug […]
Uncategorized - August 7, 2014
New findings on schizophrenia
Researchers have identified more than 100 positions in the human genome that can be connected to the risk of developing schizophrenia. An international research team, where scientists from Umeå University and Karolinska Institute take part, have presented a new study in Nature on the findings which could lead to new methods to treat the disease. […]
Financing - August 6, 2014
Novo Nordisk shares going steadily up
Danish Novo Nordisk shares are rising steadily this year, zooming past British competitor GlaxoSmithKline. Bloomberg recently reported that the company’s shares have gone up by 27 percent during 2014 with a total market cap of $120 billion, passing GSK by several billions which according to stock exchange experts comes as quite a surprise. Its 2014 sales forecast amounts to […]
Drug Development Pharma - August 6, 2014
Boehringer Ingelheim returns project to Orexo
Orexo has announced that Boehringer Ingelheim has decided to return the OX-MPI project to Orexo. The project aims to develop products based on specific inhibition of prostaglandin E2 (PGE2) in different disease conditions. Since 2005, Boehringer Ingelheim has been responsible for all research and development within the project. Orexo will evaluate the results from Boehringer Ingelheim. When […]
Uncategorized - August 6, 2014
Big interest for AstraZeneca summer research school
The interest for AstraZeneca’s summer research school 2014 that started at Gothenburg University on August 4 has been high reports the company. The waiting lists have been long and the school were out of vacancies quickly, according to AstraZeneca. 53 students aged 14-17 participates in laboratories, lessons and study visits which are held at the laboratories of […]
